+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07088874

Studying New Kidney Damage Markers to Predict Acute and Chronic Kidney Problems After Radical Nephrectomy Surgery

Led by Peking University First Hospital · Updated on 2025-09-08

60

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating the use of new kidney-related biomarkers to predict acute kidney injury AKI and long-term chronic kidney disease CKD in patients undergoing radical nephrectomy, a surgery to remove a kidney. AKI occurs in over 40% of these patients, and current diagnostic methods relying on serum creatinine and urine output have limitations such as delayed response and inaccuracy. This study aims to evaluate how well these novel biomarkers can detect kidney injury early and predict kidney disease up to one year after surgery. Participants scheduled for unilateral radical nephrectomy will be monitored for specific urinary and blood biomarkers, including TIMP-2IGFBP-7, NGAL, KIM-1, and serum cystatin C. The study groups include patients who develop AKI or newworsening CKD after surgery and those who do not. Biomarker levels will be assessed within 7 days post-surgery to predict AKI and up to one year to evaluate CKD outcomes. Researchers will also examine combinations of biomarkers and clinical risk factors to improve prediction accuracy. During the study, participants will undergo biomarker testing at specified times after surgery, with follow-up assessments extending up to one year. Researchers will review urinary and blood samples to measure kidney function changes and correlate biomarker levels with kidney injury outcomes. The main focus is on how well these biomarkers predict AKI within the first week and CKD within one year after nephrectomy, helping to identify patients at risk and guide future care approaches.

CONDITIONS

Brief Title

Novel Biomarkers and Postoperative Kidney Injury in Radical Nephrectomy

Research Team

Q

Qiongfang Wu, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here